Medical devices, healthcare technology and the business of care
510(k) clearance · K260801

Sensinel Cardiopulmonary Management (CPM) System

Analog Devices · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK260801

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 16 October 2026 for the Sensinel Cardiopulmonary Management (CPM) System, submitted by Analog Devices of Wilmington, Massachusetts, under 510(k) number K260801. The application was received on 11 March 2026 and reviewed through the traditional pathway by the Cardiovascular panel; the agency lists it as not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. SESE denotes 510(k) clearance rather than PMA approval.

The listed classification is product code MWI, regulation 870.2300, physiological patient monitor without arrhythmia detection or alarms, with subsequent product codes BZQ, DPS, DQD, DSB, DXH and FLL. The record does not identify which components or modifications were assessed, the predicates cited, or any performance data, so the basis for the equivalence finding and the cleared indications remain unknown from this page.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260801
Regulatory pathway
510(k) premarket notification
Product code
MWI
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms).

Product code
MWI
FDA device class
2

FDA decision timeline

  1. K260801 received

    Application receipt date recorded by FDA.

  2. K260801 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MWI

Product / regulatory recordCompanyPathwayDecision dateSource
Infinium Medical, Inc.510(k) clearanceAug 14, 2026FDA
Masimo Corporation510(k) clearanceAug 12, 2026FDA
Biotracker, LLC510(k) clearanceJun 26, 2026FDA
Midmark Corporation510(k) clearanceJun 12, 2026FDA
Cosinuss GmbH510(k) clearanceApr 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Analog Devices

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Wilmington, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records